The increased reimbursement makes out product more competitive as doctors receive a larger rebate so increases the likeliness of surgeons recommending/using our technology and thus will should lead to a significant increase in sales
The increased reimbursement makes out product more competitive...
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $53.82M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 22.0¢ | $229.1K | 980.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 110004 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 26972 | 2 |
View Market Depth
| Last trade - 13.38pm 26/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |